SYNCOM FORMULATIONS (INDIA)
Back to All Ratios
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 0.58 | 0.32 | 0.26 | 0.28 | 0.17 |
What is the latest Cash Earnings per Share (CEPS) ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2025 | 0.58 |
| Mar2024 | 0.32 |
| Mar2023 | 0.26 |
| Mar2022 | 0.28 |
| Mar2017 | 0.17 |
How is Cash Earnings per Share (CEPS) of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | 0.58 | 81.25 | |
| Mar2024 | 0.32 | 23.08 | |
| Mar2023 | 0.26 | -7.14 | |
| Mar2022 | 0.28 | 64.71 | |
| Mar2017 | 0.17 | - | |
Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,420.3 Cr | -2.1% | -6.2% | -28% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,068.0 Cr | -0.7% | 7.4% | -0.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,847.0 Cr | -0.1% | -4.8% | 3.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,985.0 Cr | 2.2% | 6.3% | 11.4% | Stock Analytics | |
| CIPLA | ₹122,826.0 Cr | -0.6% | 1.2% | NA | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,418.0 Cr | 1.5% | 6.4% | 4.8% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -2.1% |
-6.2% |
-28% |
| SENSEX | 0% |
2.7% |
6.8% |
You may also like the below Video Courses